Biomerica Inc (BMRA)

$2.19 +0.11 (5.29%)
Market Cap 6.46M
Revenue (ttm) 5.31M
Net Income (ttm) -4.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -93.60%
Debt to Equity Ratio 0.00
Volume 54,000
Avg Vol 19,634
Day's Range N/A - N/A
Shares Out 3.02M
Stochastic %K 86%
Beta 0.21
Analysts Strong Buy
Price Target $13.00

Company Profile

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 645 2111
Fax: 949 553 1231
Address:
17571 Von Karman Avenue, Irvine, United States
LewisDaKat
LewisDaKat Mar. 18 at 7:30 PM
$BMRA Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect(TM)) from One of the Largest Clinical Laboratory Chains in Europe https://marketwirenews.com/stock/bmra/news/biomerica-receives-first-commercial-order-for-its-h--4974515943106797.html?utm_source=stocktwits
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Mar. 18 at 12:31 PM
$BMRA https://investors.biomerica.com/news/news-details/2026/Biomerica-Receives-First-Commercial-Order-for-its-H--pylori-test-Hp-Detect-from-One-of-the-Largest-Clinical-Laboratory-Chains-in-Europe/default.aspx
0 · Reply
DARKP00L
DARKP00L Mar. 18 at 12:21 PM
$BMRA 08:21 on Mar. 18 2026 Biomerica Receives First Commercial Order For Hp Detect, Helicobacter Pylori Diagnostic Stool Antigen Test #tradeideas
0 · Reply
Stock_Catcher
Stock_Catcher Mar. 18 at 12:19 PM
$BMRA ​​BMRA Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 11 at 1:06 AM
$BMRA RSI: 50.00, MACD: -0.0759 Vol: 0.11, MA20: 2.14, MA50: 2.37 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
DARKP00L
DARKP00L Mar. 5 at 1:43 PM
$BMRA 08:21 on Mar. 05 2026 Biomerica Receives Registration From UK Medicines & Healthcare Products Regulatory Agency (MHRA) For hp+detect Diagnostic Tests For H. pylori bacteria #tradeideas
0 · Reply
DARKP00L
DARKP00L Mar. 5 at 1:35 PM
$BMRA 08:21 on Mar. 05 2026 Biomerica Receives Registration From UK Medicines & Healthcare Products Regulatory Agency (MHRA) For hp+detect Diagnostic Tests For H. pylori bacteria #tradeideas
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Mar. 5 at 1:21 PM
$BMRA https://investors.biomerica.com/news/default.aspx
0 · Reply
TheTradeXchange
TheTradeXchange Mar. 5 at 1:19 PM
$BMRA - Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great BritainRegistration marks the Company’s entry into the UK market, where H. pylori affects an estimated 45% of the population across Europe’s five largest countries
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Feb. 26 at 1:33 PM
$BMRA https://investors.biomerica.com/news/news-details/2026/Biomerica-Reports-Real-World-Data-Nearly-60-of-IBS-Patients-Achieved-Clinically-Meaningful-Pain-Reduction-and-68-Achieved-Bloating-Reduction-with-the-inFoods-IBS-Therapy/default.aspx
0 · Reply
Latest News on BMRA
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe

Mar 18, 2026, 8:19 AM EDT - 3 days ago

Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe

Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain

Mar 5, 2026, 8:19 AM EST - 16 days ago

Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain

Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy

Feb 26, 2026, 8:19 AM EST - 23 days ago

Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy

Vietnam Approves Biomerica's EZ Detect™ for Nationwide Distribution

Feb 18, 2026, 8:19 AM EST - 4 weeks ago

Vietnam Approves Biomerica's EZ Detect™ for Nationwide Distribution

Biomerica Reports Second Quarter Fiscal 2026 Financial Results

Jan 14, 2026, 5:17 PM EST - 2 months ago

Biomerica Reports Second Quarter Fiscal 2026 Financial Results

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test

Dec 23, 2025, 8:19 AM EST - 3 months ago

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test

Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio

Dec 11, 2025, 8:08 AM EST - 3 months ago

Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio

Biomerica's inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

Nov 25, 2025, 8:19 AM EST - 4 months ago

Biomerica's inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

Nov 6, 2025, 8:19 AM EST - 4 months ago

Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods® IBS Test in the U.S.

Oct 16, 2025, 8:19 AM EDT - 5 months ago

Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods® IBS Test in the U.S.

Biomerica Reports First Quarter Fiscal 2026 Financial Results

Oct 15, 2025, 9:27 AM EDT - 5 months ago

Biomerica Reports First Quarter Fiscal 2026 Financial Results

Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

Oct 8, 2025, 8:19 AM EDT - 5 months ago

Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

Sep 9, 2025, 8:08 AM EDT - 6 months ago

Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Test for Home Use

Sep 3, 2025, 8:19 AM EDT - 7 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Test for Home Use

Biomerica Reports Fiscal 2025 Year End Results

Aug 29, 2025, 5:12 PM EDT - 7 months ago

Biomerica Reports Fiscal 2025 Year End Results

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Home Use

Aug 14, 2025, 8:19 AM EDT - 7 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Home Use

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

Jul 2, 2025, 8:08 AM EDT - 9 months ago

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

Jun 26, 2025, 8:19 AM EDT - 9 months ago

Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

Jun 6, 2025, 9:30 AM EDT - 10 months ago

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

Jun 5, 2025, 8:19 AM EDT - 10 months ago

Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System

May 22, 2025, 8:19 AM EDT - 10 months ago

Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System

PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement

May 7, 2025, 8:19 AM EDT - 11 months ago

PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection

Apr 23, 2025, 8:19 AM EDT - 11 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage

Apr 17, 2025, 8:19 AM EDT - 1 year ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage

Biomerica Announces Reverse Stock Split

Apr 16, 2025, 9:00 AM EDT - 1 year ago

Biomerica Announces Reverse Stock Split

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis

Feb 26, 2025, 8:19 AM EST - 1 year ago

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis

Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Feb 19, 2025, 8:19 AM EST - 1 year ago

Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval

Jan 16, 2025, 10:49 AM EST - 1 year ago

Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Jan 16, 2025, 8:19 AM EST - 1 year ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Jan 15, 2025, 8:19 AM EST - 1 year ago

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis

Nov 21, 2024, 8:19 AM EST - 1 year ago

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

Nov 7, 2024, 9:09 AM EST - 1 year ago

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Oct 30, 2024, 8:19 AM EDT - 1 year ago

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Biomerica Reports First Quarter Fiscal 2025 Financial Results

Oct 16, 2024, 9:00 AM EDT - 1 year ago

Biomerica Reports First Quarter Fiscal 2025 Financial Results

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

Sep 4, 2024, 8:19 AM EDT - 1 year ago

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

Biomerica Reports Fiscal 2024 Year End Results

Aug 29, 2024, 9:00 AM EDT - 1 year ago

Biomerica Reports Fiscal 2024 Year End Results

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers

Jul 1, 2024, 7:47 AM EDT - 1 year ago

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers

Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

May 13, 2024, 8:19 AM EDT - 2 years ago

Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

Apr 29, 2024, 8:19 AM EDT - 2 years ago

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

Biomerica provides update on inFoods® IBS expansion

Apr 15, 2024, 7:47 AM EDT - 2 years ago

Biomerica provides update on inFoods® IBS expansion

Biomerica Reports Third Quarter 2024 Financial Results

Apr 12, 2024, 7:23 PM EDT - 2 years ago

Biomerica Reports Third Quarter 2024 Financial Results

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Mar 28, 2024, 8:19 AM EDT - 2 years ago

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Feb 21, 2024, 8:19 AM EST - 2 years ago

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

Jan 23, 2024, 8:19 AM EST - 2 years ago

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

Biomerica Reports Second Quarter 2024 Financial Results

Jan 16, 2024, 8:19 AM EST - 2 years ago

Biomerica Reports Second Quarter 2024 Financial Results

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

Dec 18, 2023, 7:47 AM EST - 2 years ago

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

Nov 10, 2023, 8:19 AM EST - 2 years ago

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

Nov 8, 2023, 8:19 AM EST - 2 years ago

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

Oct 13, 2023, 1:10 PM EDT - 2 years ago

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

Biomerica Reports First Quarter 2024 Financial Results

Oct 13, 2023, 6:39 AM EDT - 2 years ago

Biomerica Reports First Quarter 2024 Financial Results

LewisDaKat
LewisDaKat Mar. 18 at 7:30 PM
$BMRA Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect(TM)) from One of the Largest Clinical Laboratory Chains in Europe https://marketwirenews.com/stock/bmra/news/biomerica-receives-first-commercial-order-for-its-h--4974515943106797.html?utm_source=stocktwits
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Mar. 18 at 12:31 PM
$BMRA https://investors.biomerica.com/news/news-details/2026/Biomerica-Receives-First-Commercial-Order-for-its-H--pylori-test-Hp-Detect-from-One-of-the-Largest-Clinical-Laboratory-Chains-in-Europe/default.aspx
0 · Reply
DARKP00L
DARKP00L Mar. 18 at 12:21 PM
$BMRA 08:21 on Mar. 18 2026 Biomerica Receives First Commercial Order For Hp Detect, Helicobacter Pylori Diagnostic Stool Antigen Test #tradeideas
0 · Reply
Stock_Catcher
Stock_Catcher Mar. 18 at 12:19 PM
$BMRA ​​BMRA Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 11 at 1:06 AM
$BMRA RSI: 50.00, MACD: -0.0759 Vol: 0.11, MA20: 2.14, MA50: 2.37 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
DARKP00L
DARKP00L Mar. 5 at 1:43 PM
$BMRA 08:21 on Mar. 05 2026 Biomerica Receives Registration From UK Medicines & Healthcare Products Regulatory Agency (MHRA) For hp+detect Diagnostic Tests For H. pylori bacteria #tradeideas
0 · Reply
DARKP00L
DARKP00L Mar. 5 at 1:35 PM
$BMRA 08:21 on Mar. 05 2026 Biomerica Receives Registration From UK Medicines & Healthcare Products Regulatory Agency (MHRA) For hp+detect Diagnostic Tests For H. pylori bacteria #tradeideas
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Mar. 5 at 1:21 PM
$BMRA https://investors.biomerica.com/news/default.aspx
0 · Reply
TheTradeXchange
TheTradeXchange Mar. 5 at 1:19 PM
$BMRA - Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great BritainRegistration marks the Company’s entry into the UK market, where H. pylori affects an estimated 45% of the population across Europe’s five largest countries
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Feb. 26 at 1:33 PM
$BMRA https://investors.biomerica.com/news/news-details/2026/Biomerica-Reports-Real-World-Data-Nearly-60-of-IBS-Patients-Achieved-Clinically-Meaningful-Pain-Reduction-and-68-Achieved-Bloating-Reduction-with-the-inFoods-IBS-Therapy/default.aspx
0 · Reply
BigPennyStockAlerts
BigPennyStockAlerts Feb. 26 at 1:29 PM
$BMRA- $2.31 Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
0 · Reply
Stock_Catcher
Stock_Catcher Feb. 26 at 1:19 PM
$BMRA Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 24 at 10:06 PM
$BMRA RSI: 35.00, MACD: -0.0949 Vol: 0.10, MA20: 2.27, MA50: 2.45 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Stock_Catcher
Stock_Catcher Feb. 18 at 1:19 PM
$BMRA Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 17 at 11:36 AM
$BMRA Current Stock Price: $2.29
0 · Reply
trader2360
trader2360 Feb. 10 at 8:17 PM
$BMRA
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Feb. 6 at 2:45 PM
$BMRA
0 · Reply
CarOrbitsMars
CarOrbitsMars Jan. 29 at 11:57 PM
$BMRA Come on Pooper BR549!
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 16 at 12:00 AM
$BMRA RSI: 51.52, MACD: 0.0644 Vol: 0.16, MA20: 2.60, MA50: 2.48 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Jan. 7 at 7:42 PM
$BMRA
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 27 at 3:28 AM
$BMRA Current Stock Price: $2.73
0 · Reply
ALLBulls_Blitz
ALLBulls_Blitz Dec. 26 at 9:20 PM
$$RZLV quirky as hell... Looking up Stayed heavy with $BMRA also, fkrs got to pop soon. see yall next week Lets go to the gym punish my legs, and shoulders Finish up at the pub Godspeed
0 · Reply